Margit Juhasz, MD
MOHS-Micrographic Surgery · Burien, WANPI 1225488208
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,995 of the $2,739 with a category attached, or 72.8%. 18 manufacturers reported payments, led by Pfizer at 45.1% of the total.
Across 64 payments — averaging $42.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- Sanofi$253
- Johnson & Johnson$229
- AbbVie$226
- Amgen$156
- Boehringer Ingelheim$106
- plus $536 from 12 others
Across 1 payment — averaging $2810.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merz North America, Inc.$3K
What the payments were for
- Speaking & faculty fees$913%
- Travel & lodging$65424%
- Food & beverage$1,99573%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 17 | $1,234 |
| Sanofi | 3 | $253 |
| Johnson & Johnson | 12 | $229 |
| AbbVie | 8 | $226 |
| Amgen | 2 | $156 |
| Boehringer Ingelheim | 2 | $106 |
| EPI Health, LLC | 1 | $91 |
| Incyte Corporation | 3 | $64 |
| Lilly USA, LLC | 3 | $62 |
| Arcutis Biotherapeutics, Inc. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Kaleo, Inc. | 1 | $46 |
| Regeneron | 1 | $45 |
| UCB, Inc. | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Organon | 1 | $20 |
| Organogenesis Inc. | 1 | $20 |
| Novartis | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,739 in reported general payments places this provider in the 65th percentile of 38 mohs-micrographic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 12 | $1,057 |
| Clobetasol Propionate | 19 | $759 |
| Ketoconazole | 45 | $656 |
| Mupirocin | 34 | $305 |
| Doxycycline Monohydrate | 11 | $182 |
| Cephalexin | 40 | $152 |
| Triamcinolone Acetonide | 15 | $150 |
| Minoxidil | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Burien
- Ein Gun SongMill Creek$4.5M
- Jeremy PeckRichland$9K
- Marcus TanRenton$8K
- Mikel MuseVancouver$6K
- Jennifer ReichelSeattle$5K
- Kirk EcklundYakima$5K
- John NiaSpokane$5K
- Mustufa JafryMill Creek$4K
- Maureen MooneyUniversity Place$4K
- Nobuyoshi KageyamaRenton$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.